medmira
medmira.com
Actively hiring
Biotechnology
Diagnostic Tests & IVD
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
MedMira Launches Rapid Vaccinia Antibody Detection Test Infection Control Today
Infection Control Today serves infection control, facility, and C-suite leaders with strategies on HAIs, patient care, safety, and quality outcomes
Read more
Report
Health Canada approves MedMira's Reveal Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
Halifax, Nova Scotia, 26 August 2025 - MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received approval from Health Canada for its Reveal TP (Syphilis) Antibody Test (Reveal TP) - the fastest standalone screening device for syphilis in Can
Read more
Report
MedMira Announces Launch of Clinical Trial for Its Multiplo TP/HIV Self-Test in Canada
Halifax, Nova Scotia, July 16, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate MedMira's Multiplo TP/HIV rapid test for use as a self-test in Ca
Read more
Report
MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal G4 HIV-1/2 rapid test for VA, Department of Defence
Halifax, Nova Scotia, 17th of April, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) and Lovell Government Services announced today that they have partnered to serve federal healthcare systems such as the Veterans Health Administration (VHA), the Military Healt
Read more
Report
MedMira Announces Partnership with MediGroup Physician Services in the United States
MedMira Inc. (MedMira) (TSXV:MIR) announced today its partnership with MediGroup, a leader in the US health care industry since 1999. This new par ...
Read more
Report
MedMira Announces Partnership with MediGroup Physician Services in the United States
Halifax, Nova Scotia, 27th of February, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) announced today its partnership with MediGroup, a leader in the US health care industry since 1999. This new partnership allows the Company to promote and sell its products
Read more
Report
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
Halifax, Nova Scotia, 25th of February, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) announced today its exclusive distribution agreement with Trimedic Inc. for the Canadian market. This partnership allows MedMira to expedite its growth in the Canadian marke
Read more
Report
MedMira Receives Investigational Testing Authorizations for Multiplo TP/HIV Self-Test and Non-Professional Use Applications
Halifax, Nova Scotia, 21st of January, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received Investigational Testing Authorizations (ITAs) from Health Canada to begin clinical trials for new label claim applications of its recentl
Read more
Report
MedMira receives Health Canada approval for its Reveal G4 Rapid HIV-1/2 Test for Point-of-Care use
Halifax, Nova Scotia - January 14, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received today the approval from Health Canada for its Reveal Rapid G4 HIV-1/2 Test (Reveal HIV test) for Point-of-Care (POC) use. The Reveal HIV rapi
Read more
Report
MedMira receives investigational testing authorization for its Multiplo Complete Syphilis (TP/nTP) Antibody Test
Halifax, Nova Scotia, 9 January, 2025 - Today, MedMira Inc. (MedMira) (TSXV: MIR) announced that its received investigational testing authorization (ITA) from Health Canada to begin clinical trials for its Multiplo Complete Syphilis (TP/nTP) Antibody Test
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Halifax
Canada
Regional office
Reach out to us
500-1000 est. staff